ImmunoScape Announces Memorandum of Understanding for Clinical Trial with Premier U.S. Cancer Center
Singapore: ImmunoScape Pte. Ltd., an ASTAR spin-out backed by Amgen Ventures and EDBI, has announced the execution of a Memorandum of Understanding (MOU) with a leading NCI-designated Comprehensive Cancer Center in the United States, known for its sig…